Robot-assisted retroperitoneal lymph node dissection as primary treatment for stage II seminoma germ cell tumor
ABSTRACT Introduction: Historically, therapeutic avenues for patients with clinical stage II seminoma germ cell tumors (SGCT) were confined to radiotherapy and chemotherapy. While survival rates with these modalities are commendable, both entail substantial long-term morbidities. Furthermore, this...
Main Authors: | Stefano Cogo Badan, Willy Baccaglini, Arie Carneiro, Gustavo Caserta Lemos |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2024-04-01
|
Series: | International Brazilian Journal of Urology |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382024000200225&tlng=en |
Similar Items
-
Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
by: Muhannad Alsyouf, et al.
Published: (2023-03-01) -
Robotic post-chemotherapy retroperitoneal lymph node dissection
by: Simone Vernez, et al.
Published: (2024-06-01) -
Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer
by: George McClintock, et al.
Published: (2024-01-01) -
Red Out: Bleeding During Robotic Retroperitoneal Lymph Node Dissection and Strategies To Manage It
by: Fairleigh Reeves, et al.
Published: (2023-02-01) -
Unilateral post-chemotherapy robot-assisted retroperitoneal lymph node dissection in Stage II non-seminomatous germ cell tumor: A tertiary care experience
by: Dario Franzese, et al.
Published: (2023-10-01)